This content is machine translated Update 2025 Hypercholesterolemia The past 18 months have noticeably shifted the LDL-lowering landscape: An ESC/EAS-Focused Update 2025 sharpens the indication thresholds, real-world data confirm the benefit of early combinations after myocardial infarction, bempedoic...…
View Post 3 min This content is machine translated Case report: Acute rheumatic fever ARF with myocarditis and occlusion of the RCA Acute rheumatic fever (ARF) and rheumatic heart disease continue to pose a serious health risk in most developing countries. In individual cases, however, it also occurs in industrialized countries. ARF...…
View Post 6 min This content is machine translated Lipoprotein(a) Importance of Lp(a) screening for primary prevention underpinned Numerous studies have shown that elevated Lp(a) levels are associated with the risk of a number of atherosclerotic cardiovascular diseases (ASCVD), including myocardial infarction (MI), stroke and peripheral arterial disease.…
View Post 4 min This content is machine translated Lipoprotein(a) The higher the Lp(a), the higher the long-term ASCVD risk Numerous studies have shown that elevated Lp(a) levels are associated with the risk of a number of atherosclerotic cardiovascular diseases (ASCVD), including myocardial infarction (MI), stroke and peripheral arterial disease.…
View Post 4 min This content is machine translated Sudden cardiac death after myocardial infarction New perspectives for risk stratification and prevention Sudden cardiac death (SCD) is one of the leading causes of death worldwide and is particularly common in patients who have survived a myocardial infarction (MI). Despite significant advances in…
View Post 4 min This content is machine translated Acute myocardial infarction and heart failure in young diabetics Type 2 with a poor risk profile for CVD Type 1 and type 2 diabetes differ in many ways, but both types are strongly associated with a high risk of cardiovascular complications. T2D at a young age is considered…
View Post 8 min This content is machine translated Percutaneous coronary intervention (PCI) Benefits of complete revascularization in elderly patients The benefit of complete revascularization in older patients (≥75 years) with myocardial infarction and multivessel disease is still unclear. At the ESC Congress, however, the results of the FIRE study…
View Post 3 min This content is machine translated Myocardial infarction Survived a heart attack – and now? Post-infarct management up-to date After an acute myocardial infarction, postinfarction management is the focus of treatment. To prevent another coronary event, it is essential to identify and treat appropriate risk factors. Non-drug interventions have…
View Post 8 min This content is machine translated Psoriasis What is the role of the IL23/Th17 pathway in cardiovascular comorbidities? The IL23/Th17 axis plays an important role in the pathophysiology of psoriasis. A growing body of evidence suggests that inflammatory processes are involved in many cardiovascular and metabolic diseases associated…
View Post 8 min This content is machine translated MINOCA Not harmless, but often overlooked: Myocardial infarction without coronary vessel obstruction In cardiology, MINOCA defined a new infarct subtype that is still frequently overlooked in clinical practice. However, the prognostic relevance cannot be dismissed.
View Post 2 min This content is machine translated Annual Meeting of the Swiss Brain Stroke Society, Zurich PCSK9 inhibitors keep acute coronary syndrome at bay It is well known that low LDL cholesterol reduces the risk of cardiovascular disease. But in practice, this is often easier said than done. Are PCSK9 inhibitors the solution?
